The vitamin-like dietary supplement para-aminobenzoic acid enhances the antitumor activity of ionizing radiation

International Journal of Radiation Oncology Biology Physics

Volumn 65, Issue 2, 2006, Pages 517-527

  Xavier, Sandhya ^a   MacDonald, Shannon ^a   Roth, Jennifer ^a   Caunt, Maresa ^a   Akalu, Abebe ^a   Morais, Danielle ^a   Buckley, Michael T ^a   Liebes, Leonard ^a   Formenti, Silvia C ^a   Brooks, Peter C ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Apoptosis; CDC25A; P21CIP1; Para aminobenzoic acid; Tumor growth

Indexed keywords

AMINO ACIDS; CELL CULTURE; ENZYME IMMOBILIZATION; IONIZING RADIATION; TUMORS;

APOPTOSIS; CDC25A; P21CIP1; PARA-AMINOBENZOIC ACID; TUMOR GROWTH;

VITAMINS;

4 AMINOBENZOIC ACID; CYCLIN DEPENDENT KINASE INHIBITOR 1; ENZYME CDC25A; PHOSPHATASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASSAY; BREAST CARCINOMA; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; EMBRYO; IN VITRO STUDY; IN VIVO STUDY; IONIZING RADIATION; MELANOCYTE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; VITAMIN SUPPLEMENTATION; WESTERN BLOTTING;

4-AMINOBENZOIC ACID; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CHICK EMBRYO; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DIETARY SUPPLEMENTS; MELANOCYTES; MELANOMA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; POLYMERASE CHAIN REACTION; RADIATION-SENSITIZING AGENTS;

EID: 33646266495     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.01.010     Document Type: Article

References (56)

1. Endo T., Yoshikawa M., Ebara M., et al. Immunohistochemical metallothionein expression in hepatocellular carcinoma. Relation to tumor progression and chemoresistance to platinum agents. J Gastroenterol 39 (2004) 1196-1201
2. Hutter G., and Sinha P. Proteomics for studying cancer cells and the development of chemoresistance. Proteomics 10 (2001) 1233-1248
3. Brown J.M. Therapeutic targets in radiotherapy. Int J Radiat Oncol Biol Phys 49 (2001) 319-326
4. Soengas M.S., and Lowe S.W. Apoptosis and melanoma chemoresistance. Oncogene 22 (2003) 3138-3151
5. Pak B.J., Chu W., Lu S.J., et al. Lineage-specific mechanism of drug and radiation resistance in melanoma mediated by tyrosinase-related protein 2. Cancer Metastasis Rev 20 (2001) 27-32
6. Pusztai L., Esteva F.J., Cristofanilli M., et al. Chemo-signal therapy, an emerging new approach to modify drug resistance in breast cancer. Cancer Treat Rev 25 (1999) 271-277
7. Marples B., Wouters B.G., Collis S.J., et al. Low-dose hyper-radiosensitivity. A consequence of ineffective cell cycle arrest of radiation-damaged G2-phase cells. Radiat Res 161 (2004) 247-255
8. Pawlik T.M., and Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 59 (2004) 928-942
9. Cordes N. Overexpression of hyperactive integrin-linked kinase leads to increased cellular radiosensitivity. Cancer Res 64 (2004) 5683-5692
10. Geng L., Donnelly E., McMahon G., et al. Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy. Cancer Res 61 (2001) 2413-2419
11. Xia F., and Powell S.N. The molecular basis of radiosensitivity and chemosensitivity in the treatment of breast cancer. Semin Radiat Oncol 12 (2002) 296-304
12. Gudkov A.V., and Komarova E.A. The role of p53 in determining sensitivity to radiotherapy. Nat Rev Cancer 3 (2003) 117-129
13. Demonacos C., Krstic-Demonacos M., Smith L., et al. A new effector pathway links ATM kinase with the DNA damage response. Nat Cell Biol 6 (2004) 968-976
14. Iliakis G., Wang Y., Guan J., et al. DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene 22 (2003) 5834-4847
15. Fisher D., and Mechali M. Sleeping policemen for DNA replication?. Nat Cell Biol 6 (2004) 576-577
16. Zhou B.B., and Bartek J. Targeting the checkpoint kinases. Chemosensitization versus chemoprotection. Nat Rev Cancer 4 (2004) 216-225
17. Wilson G.D. Radiation and the cell cycle, revisited. Cancer Metastasis Rev 23 (2004) 209-225
18. Falck J., Mailand N., Syljuasen R.G., et al. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410 (2001) 842-847
19. Powell S.N., DeFrank J.S., Connell P., et al. Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay. Cancer Res 55 (1995) 1643-1648
20. Xiao Z., Chen Z., Gunasekera A.H., et al. Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents. J Biol Chem 278 (2003) 21767-21773
21. Yu Q., La Rose J., Zhang H., et al. UCN-01 inhibits p53 up-regulation and abrogates gamma-radiation-induced G(2)-M checkpoint independently of p53 by targeting both of the checkpoint kinases, Chk2 and Chk1. Cancer Res 62 (2002) 5743-5748
22. Koniaras K., Cuddihy A.R., Christopoulos H., et al. Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells. Oncogene 20 (2001) 7453-7463
23. Hong Y., and Stambrook P.J. Restoration of an absent G1 arrest and protection from apoptosis in embryonic stem cells after ionizing radiation. Proc Natl Acad Sci USA 101 (2004) 14443-14448
24. Zhao H., Watkins J.L., and Piwnica-Worms H. Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints. Proc Natl Acad Sci USA 99 (2002) 14795-14800
25. Bartek J., and Lukas J. Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol 13 (2001) 738-747
26. Miyata H., Doki Y., Shiozaki H., et al. CDC25B and p53 are independently implicated in radiation sensitivity for human esophageal cancers. Clin Cancer Res 6 (2000) 4859-4865
27. Wouters B.G., Denko N.C., Giaccia A.J., et al. A p53 and apoptotic independent role for p21waf1 in tumour response to radiation therapy. Oncogene 18 (1999) 6540-6545
28. Kinnaert E., Morandini R., Simon S., et al. The degree of pigmentation modulates the radiosensitivity of human melanoma cells. Radiat Res 154 (2000) 497-502
29. Slominski A., Paus R., and Mihm M.C. Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas. selective review and hypothesis. Anticancer Res 18 (1998) 3709-3715
30. Kinnaert E., Duez P., Morandini R., et al. Cysteine but not glutathione modulates the radiosensitivity of human melanoma cells by affecting both survival and DNA damage. Pigment Cell Res 17 (2004) 275-280
31. Stephens T.C., Adams K., and Peacock J.H. Radiosensitivity of B16 melanoma is not significantly influenced by melanin content. Int J Radiat Biol 49 (1986) 169-175
32. Price P., and McMillan T.J. Use of the tetrazolium assay in measuring the response of human tumor cells to ionizing radiation. Cancer Res 50 (1990) 1392-1396
33. Brooks P.C., Roth J.M., Lymberis S.C., et al. Ionizing radiation modulates the exposure of the HUIV26 cryptic epitope within collagen type IV during angiogenesis. Int J Radiat Oncol Biol Phys 54 (2002) 1194-1201
34. Hangai M., Kitaya N., Xu J., et al. Matrix metalloproteinase-9-dependent exposure of a cryptic migratory control site in collagen is required before retinal angiogenesis. Am J Pathol 161 (2002) 1429-1437
35. Matkowsky K., Glover S., and Benya R. Quantitative immunohistochemistry. A new algorithm measuring cumulative signal strength and receptor number. Micro Anal 18 (2004) 5-6
36. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (2001) 402-408
37. Brooks P.C., Stromblad S., Sanders L.C., et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85 (1996) 683-693
38. Brooks P.C., Montgomery A.M., Rosenfeld M., et al. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79 (1994) 1157-1164
39. Brooks P.C., Clark R.A., and Cheresh D.A. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264 (1994) 569-571
40. Haffty B.G., and Glazer P.M. Molecular markers in clinical radiation oncology. Oncogene 22 (2003) 5915-5925
41. Boothman D.A., Meyers M., Odegaard E., et al. Altered G1 checkpoint control determines adaptive survival responses to ionizing radiation. Mutat Res 358 (1996) 143-153
42. Stone H.B., McBride W.H., and Coleman C.N. Modifying normal tissue damage postirradiation. Report of a workshop sponsored by the Radiation Research Program, National Cancer Institute, Bethesda, Maryland, September 6-8, 2000. Radiat Res 157 (2002) 204-223
43. Burnet N.G., Wurm R., Nyman J., et al. Normal tissue radiosensitivity, how important is it?. Clin Oncol (R Coll Radiol) 8 (1996) 25-34
44. Suzuki K., Yokoyama S., Waseda S., et al. Delayed reactivation of p53 in the progeny of cells surviving ionizing radiation. Cancer Res 63 (2003) 936-941
45. Busino L., Donzelli M., Chiesa M., et al. Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage. Nature 426 (2003) 87-91
46. Bendjennat M., Boulaire J., Jascur T., et al. UV irradiation triggers ubiquitin-dependent degradation of p21(WAF1) to promote DNA repair. Cell 114 (2003) 599-610
47. Scott S.L., Earle J.D., and Gumerlock P.H. Functional p53 increases prostate cancer cell survival after exposure to fractionated doses of ionizing radiation. Cancer Res 63 (2003) 7190-7196
48. Merritt A.J., Allen T.D., Potten C.S., et al. Apoptosis in small intestinal epithelial from p53-null mice. Evidence for a delayed, p53-independent G2/M-associated cell death after gamma-irradiation. Oncogene 14 (1997) 2759-2766
49. Falck J., Petrini J.H., Williams B.R., et al. The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nat Genet 30 (2002) 290-294
50. Sausville E.A., Arbuck S.G., Messmann R., et al. Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms. J Clin Oncol 19 (2001) 2319-2333
51. Taylor Y.C., Parsian A.J., and Duncan P.G. Differential post-irradiation caffeine response in normal diploid versus SV40-transformed human fibroblasts. Potential role of nuclear organization and protein-composition. Int J Radiat Biol 64 (1993) 57-70
52. Annabi B., Lee Y.T., Martel C., et al. Radiation induced-tubulogenesis in endothelial cells is antagonized by the antiangiogenic properties of green tea polyphenol (-) epigallocatechin-3-gallate. Cancer Biol Ther 2 (2003) 642-649
53. Liu S., Bishop W.R., and Liu M. Differential effects of cell cycle regulatory protein p21(WAF1/Cip1) on apoptosis and sensitivity to cancer chemotherapy. Drug Resist Updat 6 (2003) 183-195
54. Gartel A.L., and Tyner A.L. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 1 (2002) 639-649
55. Weiss R.H. p21Waf1/Cip1 as a therapeutic target in breast and other cancers. Cancer Cell 4 (2003) 425-429
56. Hoagland R.J. Para-aminobenzoic acid in treatment of acute rheumatic fever. Am J Med 9 (1950) 272-274